Can genome engineering be used to target cancer-associated enhancers?
about
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation.The MYC 3' Wnt-Responsive Element Drives Oncogenic MYC Expression in Human Colorectal Cancer Cells.TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1.Critical threshold levels of DNA methyltransferase 1 are required to maintain DNA methylation across the genome in human cancer cells.
P2860
Can genome engineering be used to target cancer-associated enhancers?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Can genome engineering be used to target cancer-associated enhancers?
@ast
Can genome engineering be used to target cancer-associated enhancers?
@en
Can genome engineering be used to target cancer-associated enhancers?
@nl
type
label
Can genome engineering be used to target cancer-associated enhancers?
@ast
Can genome engineering be used to target cancer-associated enhancers?
@en
Can genome engineering be used to target cancer-associated enhancers?
@nl
prefLabel
Can genome engineering be used to target cancer-associated enhancers?
@ast
Can genome engineering be used to target cancer-associated enhancers?
@en
Can genome engineering be used to target cancer-associated enhancers?
@nl
P2860
P356
P1433
P1476
Can genome engineering be used to target cancer-associated enhancers?
@en
P2860
P304
P356
10.2217/EPI.14.30
P577
2014-01-01T00:00:00Z